TX Product Manager |
Seoul |
South Korea |
International |
Innovative Medicines |
Marketing |
Jun 26, 2024 |
Sourcing Manager R&D |
Prague |
Czech Republic |
Operations |
CTS |
Procurement |
Jun 26, 2024 |
Analyst Social Media Listening |
Hyderabad (Office) |
India |
Operations |
CTS |
Marketing |
Jun 26, 2024 |
AS&T analitik (m/ž/d) |
Mengeš |
Slovenia |
Operations |
Innovative Medicines |
Quality |
Jun 26, 2024 |
Sr. Operational Scheduler |
İstanbul Kurtköy |
Turkey |
Operations |
Innovative Medicines |
Technical Operations |
Jun 26, 2024 |
Spec. DDIT ISC QNova |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 26, 2024 |
Brand Manager |
Israel |
Israel |
International |
Innovative Medicines |
Marketing |
Jun 26, 2024 |
AS&T analitik (m/ž/d) |
Ljubljana |
Slovenia |
Operations |
Innovative Medicines |
Quality |
Jun 26, 2024 |
Strategy & Operations Head, data42 |
Basel (City) |
Switzerland |
Biomedical Research |
Pharma Research |
BD&L & Strategic Planning |
Jun 26, 2024 |
Labortechniker / QC Analyst II (m/w/d), Tirol, Österreich |
Schaftenau |
Austria |
Operations |
Innovative Medicines |
Quality |
Jun 26, 2024 |
Clinical Scientific Expert I |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
Jun 26, 2024 |
Labortechniker / QC Analyst I (m/f/d) Kundl, Schaftenau |
Schaftenau |
Austria |
Operations |
Innovative Medicines |
Quality |
Jun 26, 2024 |
Data Science Innovation Fellow - Histopathology Foundation Models |
Basel (City) |
Switzerland |
Biomedical Research |
Pharma Research |
|
Jun 26, 2024 |
Associate, Record-to-Report |
Head Office (Japan) (Pharmaceuticals) |
Japan |
Finance |
CTS |
Audit & Finance |
Jun 26, 2024 |
Spec. DDIT ISC QNova |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 26, 2024 |
QC Analyst |
Sasayama |
Japan |
Operations |
Innovative Medicines |
Quality |
Jun 26, 2024 |
Spec. DDIT ISC QNova |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 26, 2024 |
Spec. DDIT ISC QNova |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 26, 2024 |
县域主任/县域主管 |
Haerbin (Heilongjiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 26, 2024 |
(高级)医药代表 /(资深)产品专员 |
Zhongshan (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 26, 2024 |
(高级)医药代表 /(资深)产品专员 |
Shenzhen (Guangdong Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 26, 2024 |
(高级)医药代表 /(资深)产品专员 |
Taiyuan (Shanxi Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 26, 2024 |
Associate Director - LAN Sol. Architect (CZ, Spain, Mexico) |
Prague |
Czech Republic |
Operations |
DATA, DIGITAL & IT |
|
Jun 25, 2024 |
Site Quality Lead - Saint-Genis-Pouilly (01) H/F |
Saint Genis Pouilly |
France |
Oncology |
ADVANCED ACCELERATOR APPLICATIONS |
Quality |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
Sr Field Medical Lead - Gene Therapy |
Santo Amaro |
Brazil |
International |
Innovative Medicines |
Research & Development |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
Mitarbeiter Pilotanlage (m/w/d) Kundl, Tirol |
Kundl |
Austria |
Operations |
Innovative Medicines |
Technical Operations |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
HTA Statistician (m/w/d) |
Munich (Non-Sales Force) (Novartis Pharma GmbH) |
Germany |
International |
Innovative Medicines |
Research & Development |
Jun 25, 2024 |
NS Therapeutic Area Biomarker Lead (Associate Director) |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
Jun 25, 2024 |
Specialist – Network Security Engineering (Proxy) |
Prague |
Czech Republic |
Operations |
CTS |
|
Jun 25, 2024 |
Business Analyst - Generative AI in Life Sciences |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 25, 2024 |
Expert GMP Auditor |
Mumbai (Office) |
India |
Operations |
Innovative Medicines |
Quality |
Jun 25, 2024 |
Principal Scientist - Neuroscience |
Cambridge (USA) |
USA |
|
Pharma Research |
Research & Development |
Jun 25, 2024 |
(高级)医药代表 /(资深)产品专员 |
Lishui (Zhejiang Province) |
China |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
Sr. Spec. DDIT ISC QNova (Quality management Novartis) |
Hyderabad (Office) |
India |
Operations |
CTS |
|
Jun 25, 2024 |
Clinical Supply Project Lead |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
Jun 25, 2024 |
Technical Project Leader |
Hyderabad (Office) |
India |
Development |
Innovative Medicines |
Research & Development |
Jun 25, 2024 |
Data Science Innovation Fellow - Renal Translational Research |
Basel (City) |
Switzerland |
Biomedical Research |
Pharma Research |
|
Jun 25, 2024 |
KM Strategist |
INSURGENTES |
Mexico |
Operations |
CTS |
Research & Development |
Jun 25, 2024 |
Principal Scientist, Clinical Genetics and Genomics |
Cambridge (USA) |
USA |
Biomedical Research |
Pharma Research |
Research & Development |
Jun 25, 2024 |
Clinical Research Associate I (CRA I) |
Field Force (England / Wales) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Jun 25, 2024 |
Key Account Manager |
Volgograd |
Russian Fed. |
International |
Innovative Medicines |
Sales |
Jun 25, 2024 |
Operational Scheduler |
İstanbul Kurtköy |
Turkey |
Operations |
Innovative Medicines |
Technical Operations |
Jun 25, 2024 |
Director, Capabilities & Engagement, Clinical Development |
London (The Westworks) |
United Kingdom |
Development |
Innovative Medicines |
Research & Development |
Jun 25, 2024 |